Newark, Pharmaceutical Innovations | featured news

FDA seizes contaminated ultrasound gel

U.S. marshals seized ultrasound gel produced by a New Jersey company after the government found two dangerous strains of bacteria in the product. The Food and Drug Administration, which announced the seizure Wednesday, did not comment on how widely the gel was distributed. But it warned health-care professionals to immediately stop using the product — “Other-Sonic Generic Ultrasound Transmission” by Pharmaceutical Innovations in Newark.

 

Subscribe to this RSS topic: Syndicate content